Articles
-
PBM Market Concentration Varies Among Payer Types
A few pharmacy benefit managers dominate each of the payer markets, and the three biggest PBMs appear to be targeting different markets.
Categorized in -
Public Trust in Drinking Water Safety is Low Globally
Even in countries with high access to basic drinking water services, including the United States, doubts about the safety of water were widespread.
Categorized in -
Got an Unaffordable or Incorrect Medical Bill? Calling Your Hospital Billing Office Will Usually Get You a Discount
Advocating for yourself can pay off when it comes to medical bills, and you may be missing out on financial relief when you don’t pick up the phone.
Categorized in -
It’s Worth Challenging That Troubling Medical Bill, Study Finds
Most who sought billing help got some relief, but those who may struggle most are less likely to reach out.
Categorized in -
If You Want Americans to Pay Attention to Climate Change, Just Call It Climate Change
Phrases like ‘climate crisis,’ ‘climate emergency’ or ‘climate justice’ might seem to escalate the urgency, but a large survey shows they don’t help and may actually hurt.
Categorized in -
Responding to Some ‘Inconvenient’ Truths About PBMs
The lack of transparency and inability of plan sponsors to assess how much pharmacy benefit managers generate in savings and how much they retain for themselves is the root issue.
Categorized in -
Study: Just Say “Climate Change” – not “Climate Emergency”
The terms “climate change” and “global warming” are more familiar to people and also generate more concern about the planet’s warming.
Categorized in -
Comments to Representatives DeGette and Bucshon on Building on the Successes of 21st Century Cures
Schaeffer Center experts provided comments to lawmakers on additional measures for enhancing or improving the effectiveness of the 21st Century Cures Act.
Categorized in -
State Mandates to Cap Out-of-Pocket Insulin Costs Are No Longer Necessary
State laws capping patients’ out-of-pocket insulin costs, though well-intentioned, have had limited impact.
Categorized in -
Study: Exploding Popularity of Ozempic and Wegovy Among Privately Insured Patients May Worsen Disparities
Publicly insured individuals who are most likely to benefit from new diabetes and obesity drugs are less likely to get them than those with private insurance.
Categorized in